Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Dilemma for Governments: How to Pay for Million-Dollar Therapies

The New York Times – Business:

A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins Stephanie Nolen and Dado Galdieri

in

Brazil, Children and Childhood, Disabilities, Drugs (Pharmaceuticals), Genetic Engineering, Genetics and Heredity, Medicine and Health, Novartis AG, Spinal Muscular Atrophy, Suits and Litigation (Civil)
←Long Covid Is Keeping Significant Numbers of People Out of Work, Study Finds
Judge To Hold Hearing Over Georgia Special Grand Jury Report→

More posts

  • How to Survive Politics Talk at Thanksgiving (Without Losing Your Mind)

  • Killer robots: U.N. talks fall short of hopes for legally binding rules

  • I’m Genuinely Very Curious If You Can Get A 17/17 On This TV Sitcom Trivia Quiz

  • Serious crash closes M42 near Birmingham Airport

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube